Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

Real-time Quote. Real-time TRADEGATE AG - 06/28 01:26:54 pm
11.7460 EUR   -1.25%
04/27 CYTOTOOLS : DermaTools signs contracts for production by a new Germa..
02/03 CYTOTOOLS : strenghthens DermaTools Biotech GmbH with a  capital inc..
2015 CYTOTOOLS : DermaPro retains its potential
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
06/22/2016 06/23/2016 06/24/2016 06/27/2016 06/28/2016 Date
12.42(c) 11.945(c) 11.595(c) 11.895(c) 11.795 Last
37 112 7 262 7 932 1 816 427 Volume
+4.46% -3.82% -2.93% +2.59% -0.84% Change
More quotes
Financials (€)
Sales 2015 1,50 M
EBIT 2015 -2,60 M
Net income 2015 -2,60 M
Finance 2015 0,20 M
Yield 2015 -
Sales 2016 2,60 M
EBIT 2016 -1,30 M
Net income 2016 -1,30 M
Debt 2016 0,50 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales2015 15,7x
EV / Sales2016 9,34x
Capitalization 23,8 M
More Financials
Company
CytoTools AG operates as a biotechnology company, which develops therapeutic from research on programmed death cell.The company was founded by Dirk Kaiser and Mark-Andre Freyberg in 2000 and is headquartered in Darmstadt, Germany. 
More about the company
Latest news on CYTOTOOLS AG
05/23 DGAP-NEWS : CytoTools AG: Resultate aus der Phase II/III Studie zur Behandlung d..
04/27 CYTOTOOLS : DermaTools signs contracts for production by a new German manufactur..
04/22 DGAP-NEWS : DermaTools Biotech GmbH identifiziert neuen Hersteller für Wirkstoff..
02/03 CYTOTOOLS : strenghthens DermaTools Biotech GmbH with a  capital increase
02/03 CYTOTOOLS : stärkt das Tochterunternehmen DermaTools Biotech GmbH durch Kapitale..
01/26 CYTOTOOLS : klärt die Ursachen der zu geringen Wirkstoffkonzentration auf, die z..
2015 CYTOTOOLS : DermaPro retains its potential
2015 CYTOTOOLS : berichtet: Der Wirkstoff DermaPro(R) behält sein Potential (DGAP New..
2015 CYTOTOOLS : berichtet über Ergebnisse der europäischen klinischen Studie Phase I..
2015 CYTOTOOLS : before important milestones
More news
Sector news : Bio Therapeutic Drugs
06/27 MEDIVATION : Voted Top Workplace in San Francisco Bay Area for Fourth Year in a ..
06/25 NOVARTIS : SC requests solicitor general to consider on biosimilars
06/24DJMedpace Files for IPO
06/24DJMEDIVATION : Glass Lewis Backs Medivation Board in Sanofi Dispute
06/24 MEDIVATION : Glass Lewis Recommends Medivation's Stockholders Support the Compan..
More sector news : Bio Therapeutic Drugs
Advertisement
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions